These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32194366)

  • 41. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.
    Kim TH; Lee JH
    PLoS One; 2014; 9(11):e112512. PubMed ID: 25386854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.
    Picillo M; Santangelo G; Moccia M; Erro R; Amboni M; Prestipino E; Longo K; Vitale C; Spina E; Orefice G; Barone P; Pellecchia MT
    J Neural Transm (Vienna); 2016 Apr; 123(4):371-7. PubMed ID: 26739446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salivary FRAP as A Marker of Chronic Kidney Disease Progression in Children.
    Maciejczyk M; Szulimowska J; Taranta-Janusz K; Werbel K; Wasilewska A; Zalewska A
    Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31540400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between serum uric acid and motor subtypes of Parkinson's disease.
    Lolekha P; Wongwan P; Kulkantrakorn K
    J Clin Neurosci; 2015 Aug; 22(8):1264-7. PubMed ID: 26055955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases.
    Ni Z; Chen R
    Transl Neurodegener; 2015; 4():22. PubMed ID: 26579223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Case-Control Study of Salivary Redox Homeostasis in Hypertensive Children. Can Salivary Uric Acid be a Marker of Hypertension?
    Maciejczyk M; Taranta-Janusz K; Wasilewska A; Kossakowska A; Zalewska A
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32204502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study.
    Chen D; Wei X; Zou J; Wang R; Liu X; Xu X; Lu J; Wang Z; Tang B; Wang B; Jin K; Wang Q
    Front Cell Neurosci; 2015; 9():247. PubMed ID: 26217177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet-derived extracellular vesicles in Huntington's disease.
    Denis HL; Lamontagne-Proulx J; St-Amour I; Mason SL; Weiss A; Chouinard S; Barker RA; Boilard E; Cicchetti F
    J Neurol; 2018 Nov; 265(11):2704-2712. PubMed ID: 30209650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington's Disease.
    Reyes A; Salomonczyk D; Teo WP; Medina LD; Bartlett D; Pirogovsky-Turk E; Zaenker P; Bloom JC; Simmons RW; Ziman M; Gilbert PE; Cruickshank T
    Sci Rep; 2018 Oct; 8(1):14615. PubMed ID: 30279429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.
    Maetzler W; Stapf AK; Schulte C; Hauser AK; Lerche S; Wurster I; Schleicher E; Melms A; Berg D
    J Alzheimers Dis; 2011; 27(1):119-26. PubMed ID: 21765209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Grasping premanifest Huntington's disease - shaping new endpoints for new trials.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Dec; 25(16):2858-62. PubMed ID: 20818671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prefrontal executive function associated coupling relates to Huntington's disease stage.
    Unschuld PG; Liu X; Shanahan M; Margolis RL; Bassett SS; Brandt J; Schretlen DJ; Redgrave GW; Hua J; Hock C; Reading SA; van Zijl PC; Pekar JJ; Ross CA
    Cortex; 2013; 49(10):2661-73. PubMed ID: 23906595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukocyte telomere shortening in Huntington's disease.
    Scarabino D; Veneziano L; Peconi M; Frontali M; Mantuano E; Corbo RM
    J Neurol Sci; 2019 Jan; 396():25-29. PubMed ID: 30396032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.